Focus on infection and sepsis 2017

Martín‐Loeches, Ignacio; Garnacho-Montero, José; Nseir, Saad

doi:10.1007/s00134-017-4787-z

Cited by 7 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sepsis patient's condition develops swiftly. Although we treat well and monitor strictly, both sepsis morbidity and mortality remains high, it is a typical problem in global medical field [11] . At the early stage of sepsis, it is very important to reduce mortality by timely and targeted treatment.…”

Section: Resultsmentioning

confidence: 99%

Evaluation of the Clinical Efficacy of Liquid Resuscitation Combined with Ulinastatin in Patients with Sepsis

Sun¹,

Li²,

Wang³

et al. 2022

ijps

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Evaluation of the Clinical Efficacy of Liquid Resuscitation Combined with Ulinastatin in Patients with Sepsis

Sun¹,

Li²,

Wang³

et al. 2022

ijps

View full text Add to dashboard Cite

“…It is also a potential source of bias the inclusion of less severely ill patients throughout a quality improvement initiative because of increased awareness. [ 13 ] However, the association between time to antibiotics and mortality is demonstrated considering all individuals, both those included at the baseline period and during the intervention.…”

mentioning

confidence: 99%

Antibiotic stewardship: Dead bugs do not mutate

Martín‐Loeches

Léone²,

Einav

2022

Journal of Translational Internal Medicine

Self Cite

View full text Add to dashboard Cite

“…Patients admitted to an ICU due to sepsis and with the need of organ support have a high mortality rate (1). The Surviving Sepsis Campaign (SSC) has previously made very specific recommendations to be implemented to fight sepsis (2).…”

mentioning

confidence: 99%

Surviving Sepsis Campaign: Research Opportunities for Infection and Blood Purification Therapies

Martín‐Loeches

Nunnally

Hellman

et al. 2021

Critical Care Explorations

Self Cite

View full text Add to dashboard Cite

OBJECTIVES: Patients with infection can develop sepsis, and their mortality can be high. An important aspect in the treatment of sepsis is adequate management of the infection. DATA SOURCES: Using a modified Delphi approach, the Surviving Sepsis Campaign research committee recently published a series of 26 priorities for sepsis and septic shock. STUDY SELECTION: Task force members with specific expertise were tasked with generating expanded reviews for all infection questions and a subset of adjunctive therapy questions from the larger list of sepsis priorities. Each question was addressed by one of the six task force members. DATA EXTRACTION: In-depth reviews were then edited by the group as a whole, with added input from the committee cochairs. DATA SYNTHESIS: Six questions were addressed: 1) should empiric antibiotic combination therapy be used in sepsis or septic shock? 2) does optimization of antimicrobial pharmacokinetics and pharmacodynamics impact patient outcomes in sepsis? 3) should viral reactivation resulting from sepsis-induced immunosuppression be treated with antiviral therapy in critically ill septic patients? 4) should rapid diagnostic tests be implemented in clinical practice? 5) what is the role of lung-protective ventilation in sepsis patients without acute respiratory distress syndrome? and 6) how do we determine the efficacy of “blood purification” therapies such as endotoxin absorbers, cytokine absorbers, and plasmapheresis. CONCLUSIONS: The research committee members for the Surviving Sepsis Campaign aimed to explore research questions in order to provide existing evidence and highlight areas of uncertainty and future directions.

show abstract

Focus on infection and sepsis 2017

Cited by 7 publications

References 21 publications

Evaluation of the Clinical Efficacy of Liquid Resuscitation Combined with Ulinastatin in Patients with Sepsis

Evaluation of the Clinical Efficacy of Liquid Resuscitation Combined with Ulinastatin in Patients with Sepsis

Antibiotic stewardship: Dead bugs do not mutate

Surviving Sepsis Campaign: Research Opportunities for Infection and Blood Purification Therapies

Contact Info

Product

Resources

About